PHARMA PRODUCTION ApS Financials, key figures and credit report
Gross profit 19.1 kDKK FY 2025 -87.8% vs 2024
EBIT 14.1 kDKK FY 2025 -89.2% vs 2024
Net debt 2 924.0 kDKK FY 2025 -11.1% vs 2024
Quick ratio 0.1 FY 2025 +0 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | 130.05 | ||||
| Gross profit | 496.44 | 710.04 | 694.94 | 155.80 | 19.08 |
| Employee benefit expenses | - 388.94 | - 468.89 | -51.50 | -25.75 | -4.98 |
| EBIT | 107.50 | 241.15 | 643.44 | 130.05 | 14.09 |
| Other financial income | 193.53 | 423.79 | 92.30 | 12.81 | 0.05 |
| Other financial expenses | - 184.02 | - 180.63 | - 243.39 | - 169.11 | - 136.78 |
| Pre-tax profit | 117.02 | 484.31 | 492.34 | -26.24 | - 122.64 |
| Income taxes | -26.06 | - 107.39 | - 108.32 | 5.77 | 26.98 |
| Net earnings | 90.95 | 376.92 | 384.03 | -20.47 | -95.66 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Land and waters | 25 000.00 | 25 000.00 | 25 000.00 | 25 000.00 | |
| Buildings | 25 000.00 | ||||
| Tangible assets total | 25 000.00 | 25 000.00 | 25 000.00 | 25 000.00 | 25 000.00 |
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Current amounts owed by group member comp. | 20.84 | 45.46 | 57.54 | 78.15 | 78.15 |
| Current other receivables | 158.06 | 18.78 | 121.82 | 102.22 | 142.39 |
| Short term receivables total | 178.89 | 64.24 | 179.36 | 180.38 | 220.55 |
| Cash and bank deposits | 533.82 | 488.77 | 545.08 | 62.76 | 91.80 |
| Cash and cash equivalents | 533.82 | 488.77 | 545.08 | 62.76 | 91.80 |
| Balance sheet total (assets) | 25 712.71 | 25 553.00 | 25 724.44 | 25 243.13 | 25 312.35 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 400.00 | 400.00 | 400.00 | 400.00 | 400.00 |
| Retained earnings | 15 333.35 | 15 424.30 | 15 801.23 | 16 185.25 | 16 164.78 |
| Profit of the financial year | 90.95 | 376.92 | 384.03 | -20.47 | -95.66 |
| Shareholders equity total | 15 824.30 | 16 201.23 | 16 585.25 | 16 564.78 | 16 469.13 |
| Provisions | 3 487.00 | 3 487.00 | 3 487.00 | 3 487.00 | 3 487.00 |
| Non-current loans from credit institutions | 4 355.91 | 3 984.76 | 3 680.75 | 3 352.35 | 3 015.83 |
| Non-current other liabilities | 240.94 | 242.74 | |||
| Non-current liabilities total | 4 355.91 | 4 225.69 | 3 923.49 | 3 352.35 | 3 015.83 |
| Current loans from credit institutions | 380.00 | 380.00 | |||
| Current trade creditors | 11.68 | 7.71 | 0.15 | 0.40 | 29.59 |
| Short-term deferred tax liabilities | 115.40 | 136.03 | 218.28 | 110.89 | 110.89 |
| Other non-interest bearing current liabilities | 1 538.42 | 1 115.35 | 1 510.26 | 1 727.71 | 2 199.92 |
| Current liabilities total | 2 045.50 | 1 639.09 | 1 728.69 | 1 839.01 | 2 340.39 |
| Balance sheet total (liabilities) | 25 712.71 | 25 553.00 | 25 724.44 | 25 243.13 | 25 312.35 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated